Expertise in
25
conditions

Sven G. Meuth

Ratzeburger Allee 160, 
Luebeck, SH, DE 
Expertise in
25
conditions
Ratzeburger Allee 160, 
Luebeck, SH, DE 

Overview

Sven Meuth practices practicing medicine in Luebeck, Germany.

Mr. Meuth is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Multiple Sclerosis (MS), CACH Syndrome, Relapsing Multiple Sclerosis (RMS), Tissue Biopsy, and Thrombectomy.

He is actively involved in clinical research, co-authoring 661 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Ratzeburger Allee 160, Luebeck, SH 23538, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared With an Interferon Beta 1a (Avonex®), in Participants With Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety
A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared With an Interferon Beta 1a (Avonex®), in Participants With Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety
Enrollment Status: Terminated
Publish Date: August 05, 2021
Intervention Type: Drug
Study Phase: Phase 3
A 24-week, Multicenter, Exploratory, Two Arm Study to Assess the Effect of Dimethyl Fumarate on Immune-Modulatory Action on T Cells in Patients With Relapsing Remitting Multiple Sclerosis (DIMAT-MS)
A 24-week, Multicenter, Exploratory, Two Arm Study to Assess the Effect of Dimethyl Fumarate on Immune-Modulatory Action on T Cells in Patients With Relapsing Remitting Multiple Sclerosis (DIMAT-MS)
Enrollment Status: Completed
Publish Date: October 11, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

661 Total Publications

Oxidative and nitrosative damage in multiple sclerosis.
Oxidative and nitrosative damage in multiple sclerosis.
Journal: Current opinion in neurology
Published: April 09, 2026

Frequently Asked Questions about Sven G. Meuth

Is Sven G. Meuth a top-rated expert for Multiple Sclerosis (MS)?

MediFind is an objective health platform that identifies experts based on real-world data. Sven G. Meuth is classified as an Elite expert for Multiple Sclerosis (MS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sven G. Meuth participate in research or clinical trials?

Yes. Sven G. Meuth has published 661 articles and abstracts on conditions like Multiple Sclerosis (MS). You can view a list of Sven G. Meuth's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Meuth's expertise for a condition
ConditionClose
View All 20 Advanced Conditions
View All 98 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile